Data / Form D filings / Petra Pharma Corp
Petra Pharma Corp: Form D filings
Petra Pharma Corp, a biotechnology company in New York, NY, filed 8 Form D notices with the SEC between 2016 and 2020. The latest, on March 31, 2020, reports $27.5 million sold of a $27.5 million offering to 10 investors.
Find out what Petra Pharma Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 450 E 29th St., Suite 506, New York, NY, 10016
- Phone
- (206) 957-7300
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1662118
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 31, 2020 | Amendment | $27,545,484 | $27,545,484 | $0 | 10 | Aug 30, 2018 | sec.gov |
| Oct 21, 2019 | Amendment | $23,045,484 | $20,045,484 | $3,000,000 | 10 | Aug 30, 2018 | sec.gov |
| Aug 1, 2019 | Amendment | $17,045,484 | $17,045,484 | $0 | 10 | Aug 30, 2018 | sec.gov |
| Apr 26, 2019 | Amendment | $13,343,020 | $13,343,020 | $0 | 10 | Aug 30, 2018 | sec.gov |
| Sep 13, 2018 | New notice | $10,000,005 | $10,000,005 | $0 | 9 | Aug 30, 2018 | sec.gov |
| Jan 22, 2018 | Amendment | $48,250,000 | $31,204,516 | $17,045,484 | 13 | Dec 23, 2015 | sec.gov |
| Jan 4, 2017 | Amendment | $48,250,000 | $21,204,511 | $27,045,489 | 11 | Dec 23, 2015 | sec.gov |
| Jan 6, 2016 | New notice | $10,410,478 | $9,992,200 | $418,278 | 12 | Dec 23, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steve Gillis | Director | |
| M. Johnston Erwin | Director | |
| Barbara Johnston Dalton | Director | |
| Jenna Johnston Foger | Director | |
| Paul Johnston Sekhri | Director | |
| Thong Le | Director, Promoter | |
| David Johnston McElligott | Executive Officer, Promoter | |
| David Johnston Renas | Executive Officer | |
| Albert Johnston Yu | Executive Officer | |
| Lindsay Johnston Rayle | Promoter | |
| David Johnston Schubert | Promoter | |
| Brian Johnston O'Callaghan | Executive Officer, Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Mar 30, 2020 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Petra Pharma Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.